1.Spencer, JPE (2008) Flavonoids: modulators of brain function? Br J Nutr 99, E Suppl. 1, ES60–ES77.
2.Vafeiadou, K, Vauzour, D & Spencer, JP (2007) Neuroinflammation and its modulation by flavonoids. Endocr Metab Immune Disord Drug Targets 7, 211–224.
3.Spencer, JPE (2009) The impact of flavonoids on memory: physiological and molecular considerations. Chem Soc Rev 38, 1152–1161.
4.Spencer, JPE, Vauzour, D & Rendeiro, C (2009) Flavonoids and cognition: The molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys 492, 1–9.
5.Dixon, RA & Steele, CL (1999) Flavonoids and isoflavonoids – a gold mine for metabolic engineering. Trends Plant Sci 4, 394–400.
6.Winkel-Shirley, B (2001) Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol 126, 485–493.
7.Manach, C, Scalbert, A, Morand, C et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727–747.
8.Cheynier, V (2005) Polyphenols in foods are more complex than often thought. Am J Clin Nutr 81, Suppl., 223S–229S.
9.Rice-Evans, CA, Miller, NJ & Paganga, G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20, 933–956.
10.Rice-Evans, C (2001) Flavonoid antioxidants. Curr Med Chem 8, 797–807.
11.Rice-Evans, C (1995) Plant polyphenols: free radical scavengers or chain-breaking antioxidants? Biochem Soc Symp 61, 103–116.
12.Williamson, G & Manach, C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243S–255S.
13.Manach, C, Williamson, G, Morand, C et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S–242S.
14.Scalbert, A & Williamson, G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S–2085S.
15.Spencer, JPE, Abd El, Mohsen MM, Minihane, AM et al. (2008) Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 99, 12–22; Epublication 1 August 2007.
16.Spencer, JPE, Chowrimootoo, G, Choudhury, R et al. (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458, 224–230.
17.Spencer, JPE (2003) Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr 133, Suppl., 3255S–3261S.
18.Scheline, RR (1999) Metabolism of oxygen heterocyclic compounds. CRC Handbook of Mammalian Metabolism of Plant Compounds, pp. 243–295. Boca Raton, FL: CRC Press, Inc.
19.Tzounis, X, Vulevic, J, Kuhnle, GG et al. (2008) Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr 99, 782–792.
20.Spencer, JPE, Kuhnle, GG, Williams, RJ et al. (2003) Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 372, 173–181.
21.Spencer, JPE, Schroeter, H, Crossthwaithe, AJ et al. (2001) Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radic Biol Med 31, 1139–1146.
22.Miyake, Y, Shimoi, K, Kumazawa, S et al. (2000) Identification and antioxidant activity of flavonoid metabolites in plasma and urine of eriocitrin-treated rats. J Agric Food Chem 48, 3217–3224.
23.Terao, J, Yamaguchi, S, Shirai, M et al. (2001) Protection by quercetin and quercetin 3-O-beta-D-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic Res 35, 925–931.
24.Shirai, M, Moon, JH, Tsushida, T et al. (2001) Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-D-glucuronide, on lipid peroxidation in liposomal membranes. J Agric Food Chem 49, 5602–5608.
25.Yamamoto, N, Moon, JH, Tsushida, T et al. (1999) Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch Biochem Biophys 372, 347–354.
26.da Silva, EL, Piskula, MK, Yamamoto, N et al. (1998) Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett 430, 405–408.
27.Abbott, NJ (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200, 629–638.
28.Youdim, KA, Qaiser, MZ, Begley, DJ et al. (2004) Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 36, 592–604.
29.Youdim, KA, Dobbie, MS, Kuhnle, G et al. (2003) Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85, 180–192.
30.Aasmundstad, TA, Morland, J & Paulsen, RE (1995) Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. J Pharmacol Exp Ther 275, 435–441.
31.Sperker, B, Backman, JT & Kroemer, HK (1997) The role of beta-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 33, 18–31.
32.Kroemer, HK & Klotz, U (1992) Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 23, 292–310.
33.Lin, JH & Yamazaki, M (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42, 59–98.
34.Peng, HW, Cheng, FC, Huang, YT et al. (1998) Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 714, 369–374.
35.Suganuma, M, Okabe, S, Oniyama, M et al. (1998) Wide distribution of [H-3](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771–1776.
36.Abd El, Mohsen MM, Kuhnle, G, Rechner, AR et al. (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 33, 1693–1702.
37.Abd El, Mohsen MM, Marks, J, Kuhnle, G et al. (2006) Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr 95, 51–58.
38.Talavera, S, Felgines, C, Texier, O et al. (2005) Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 53, 3902–3908.
39.Passamonti, S, Vrhovsek, U, Vanzo, A et al. (2005) Fast access of some grape pigments to the brain. J Agric Food Chem 53, 7029–7034.
40.Kalt, W, Blumberg, JB, McDonald, JE et al. (2008) Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food Chem 56, 705–712.
41.Pollard, SE, Kuhnle, GG, Vauzour, D et al. (2006) The reaction of flavonoid metabolites with peroxynitrite. Biochem Biophys Res Commun 350, 960–968.
42.Abd El, Mohsen MM, Kuhnle, G, Rechner, AR et al. (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 33, 1693–1702.
43.Halliwell, B, Zhao, K & Whiteman, M (2000) The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 33, 819–830.
44.Schroeter, H, Boyd, C, Spencer, JPE et al. (2002) MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23, 861–880.
45.Williams, RJ, Spencer, JPE & Rice-Evans, C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36, 838–849.
46.Spencer, JPE (2007) The interactions of flavonoids within neuronal signalling pathways. Gen Nutr 2, 257–273.
47.Spencer, JPE (2008) Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 67, 238–252.
48.Matter, WF, Brown, RF & Vlahos, CJ (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 186, 624–631.
49.Vlahos, CJ, Matter, WF, Hui, KY et al. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269, 5241–5248.
50.Agullo, G, Gamet-Payrastre, L, Manenti, S et al. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53, 1649–1657.
51.Gamet-Payrastre, L, Manenti, S, Gratacap, MP et al. (1999) Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 32, 279–286.
52.Kong, AN, Yu, R, Chen, C et al. (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 23, 1–16.
53.Schroeter, H, Spencer, JPE, Rice-Evans, C et al. (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358, 547–557.
54.Spencer, JPE, Rice-Evans, C & Williams, RJ (2003) Modulation of pro-survival Akt/PKB and ERK1/2 signalling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278, 34783–34793.
55.Lin, CH, Yeh, SH, Lin, CH et al. (2001) A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31, 841–851.
56.Sweatt, JD (2001) Memory mechanisms: the yin and yang of protein phosphorylation. Curr Biol 11, R391–R394.
57.Cobb, MH & Goldsmith, EJ (1995) How MAP kinases are regulated. J Biol Chem 270, 14843–14846.
58.Goldsmith, EJ & Cobb, MH (1994) Protein kinases. Curr Opin Struct Biol 4, 833–840.
59.Karin, M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270, 16483–16486.
60.Xia, Z, Dickens, M, Raingeaud, J et al. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326–1331.
61.Anderson, CN & Tolkovsky, AM (1999) A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J Neurosci 19, 664–673.
62.Bonni, A, Brunet, A, West, AE et al. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358–1362.
63.Kaplan, DR & Miller, FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10, 381–391.
64.Crossthwaite, AJ, Hasan, S & Williams, RJ (2002) Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and PI3-kinase. J Neurochem 80, 24–35.
65.Mielke, K & Herdegen, T (2000) JNK and p38 stresskinases – degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61, 45–60.
66.Yuan, J & Yankner, BA (2000) Apoptosis in the nervous system. Nature 407, 802–809.
67.Behrens, A, Sibilia, M & Wagner, EF (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21, 326–329.
68.Davis, RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252.
69.Kobuchi, H, Roy, S, Sen, CK et al. (1999) Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol 277, C403–C411.
70.Herdegen, T, Skene, P & Bahr, M (1997) The c-Jun transcription factor – bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci 20, 227–231.
71.Castagne, V & Clarke, PG (1999) Inhibitors of mitogen-activated protein kinases protect axotomized developing neurons. Brain Res 842, 215–219.
72.Castagne, V, Gautschi, M, Lefevre, K et al. (1999) Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59, 397–423.
73.Vauzour, D, Vafeiadou, K, Rice-Evans, C et al. (2007) Activation of pro-survival Akt and ERK1/2 signaling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103, 1355–1367.
74.Llorens, F, Garcia, L, Itarte, E et al. (2002) Apigenin and LY294002 prolong EGF-stimulated ERK1/2 activation in PC12 cells but are unable to induce full differentiation. FEBS Lett 510, 149–153.
75.Schroeter, H, Bahia, P, Spencer, JPE et al. (2007) (-)-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and upregulates GLUR2 in cortical neurons. J Neurochem 101, 1596–1606.
76.Spencer, JPE, Schroeter, H, Crossthwaithe, AJ et al. (2001) Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Rad Biol Med 31, 1139–1146.
77.Levites, Y, Amit, T, Youdim, MB et al. (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277, 30574–30580.
78.Reznichenko, L, Amit, T, Youdim, MB et al. (2005) Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 93, 1157–1167.
79.Davis, RJ (1999) Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 64, 1–12.
80.Leppa, S & Bohmann, D (1999) Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18, 6158–6162.
81.Ichijo, H (1999) From receptors to stress-activated MAP kinases. Oncogene 18, 6087–6093.
82.Ichijo, H, Nishida, E, Irie, K et al. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90–94.
83.Wang, XS, Diener, K, Jannuzzi, D et al. (1996) Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase kinase kinase. J Biol Chem 271, 31607–31611.
84.Matsuzawa, A & Ichijo, H (2001) Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1. J Biochem (Tokyo) 130, 1–8.
85.Schroeter, H, Williams, RJ, Matin, R et al. (2000) Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic Biol Med 29, 1222–1233.
86.Spencer, JPE, Schroeter, H, Kuhnle, G et al. (2001) Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J 354, 493–500.
87.Wang, L, Matsushita, K, Araki, I et al. (2002) Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52. E). Nephron 91, 142–147.
88.Ishikawa, Y & Kitamura, M (2000) Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int 58, 1078–1087.
89.Uchida, K, Shiraishi, M, Naito, Y et al. (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274, 2234–2242.
90.Kennedy, SG, Wagner, AJ, Conzen, SD et al. (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11, 701–713.
91.Coffer, PJ, Jin, J & Woodgett, JR (1998) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335, 1–13.
92.Miller, FD & Kaplan, DR (2001) Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 58, 1045–1053.
93.Crowder, RJ & Freeman, RS (1998) Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 18, 2933–2943.
94.Ferriola, PC, Cody, V & Middleton, E Jr (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38, 1617–1624.
95.Walker, EH, Pacold, ME, Perisic, O et al. (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6, 909–919.
96.Hirsch, EC, Hunot, S & Hartmann, A (2005) Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord 11, Suppl. 1, S9–S15.
97.McGeer, EG & McGeer, PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27, 741–749.
98.Zheng, Z, Lee, JE & Yenari, MA (2003) Stroke: molecular mechanisms and potential targets for treatment. Curr Mol Med 3, 361–372.
99.Kozuka, N, Itofusa, R, Kudo, Y et al. (2005) Lipopolysaccharide and proinflammatory cytokines require different astrocyte states to induce nitric oxide production. J Neurosci Res 82, 717–728.
100.Marcus, JS, Karackattu, SL, Fleegal, MA et al. (2003) Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia 41, 152–160.
101.Bhat, NR, Zhang, P, Lee, JC et al. (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18, 1633–1641.
102.Casper, D, Yaparpalvi, U, Rempel, N et al. (2000) Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci Lett 289, 201–204.
103.Vafeiadou, K, Vauzour, D, Lee, HY et al. (2009) The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 484, 100–109.
104.Lau, FC, Bielinski, DF & Joseph, JA (2007) Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J Neurosci Res 85, 1010–1017.
105.Chen, JC, Ho, FM, Pei-Dawn, LC et al. (2005) Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol 521, 9–20.
106.Lee, H, Kim, YO, Kim, H et al. (2003) Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 17, 1943–1944.
107.Li, R, Huang, YG, Fang, D et al. (2004) (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res 78, 723–731.
108.Afaq, F, Adhami, VM, Ahmad, N et al. (2003) Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene 22, 1035–1044.
109.Zheng, LT, Ock, J, Kwon, BM et al. (2008) Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8, 484–494.
110.Jang, S, Kelley, KW & Johnson, RW (2008) Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci USA 105, 7534–7539.
111.Bhat, NR, Feinstein, DL, Shen, Q et al. (2002) p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J Biol Chem 277, 29584–29592.
112.Barzilai, A & Melamed, E (2003) Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol Med 9, 126–132.
113.Jellinger, KA (2001) Cell death mechanisms in neurodegeneration. J Cell Mol Med 5, 1–17.
114.Spires, TL & Hannan, AJ (2005) Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS J 272, 2347–2361.
115.Joseph, J, Cole, G, Head, E et al. (2009) Nutrition, brain aging, and neurodegeneration. J Neurosci 29, 12795–12801.
116.Weinreb, O, Amit, T, Mandel, S et al. (2009) Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 4, 283–296.
117.Mandel, S & Youdim, MB (2004) Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37, 304–317.
118.Vauzour, D, Vafeiadou, K, Rodriguez-Mateos, A et al. (2008) The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 3, 115–126.
119.Joseph, J, Cole, G, Head, E et al. (2009) Nutrition, brain aging, and neurodegeneration. J Neurosci 29, 12795–12801.
120.Luo, Y, Smith, JV, Paramasivam, V et al. (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA 99, 12197–12202.
121.Mandel, SA, Amit, T, Weinreb, O et al. (2008) Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci Ther 14, 352–365.
122.Mandel, SA, Amit, T, Kalfon, L et al. (2008) Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis 15, 211–222.
123.Kalfon, L, Youdim, MB & Mandel, SA (2007) Green tea polyphenol (-)-epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection. J Neurochem 100, 992–1002.
124.Mandel, SA, Avramovich-Tirosh, Y, Reznichenko, L et al. (2005) Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14, 46–60.
125.Levites, Y, Youdim, MB, Maor, G et al. (2002) Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63, 21–29.
126.Lee, S, Suh, S & Kim, S (2000) Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 287, 191–194.
127.Levites, Y, Weinreb, O, Maor, G et al. (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78, 1073–1082.
128.Spencer, JPE, Whiteman, M, Jenner, P et al. (2002) 5-S-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J Neurochem 81, 122–129.
129.Hastings, TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64, 919–924.
130.Vauzour, D, Ravaioli, G, Vafeiadou, K et al. (2008) Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: Implications for Parkinson's disease and protection by polyphenols. Arch Biochem Biophys 476, 145–151.
131.Spencer, JPE, Jenner, P, Daniel, SE et al. (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 71, 2112–2122.
132.Vauzour, D, Vafeiadou, K & Spencer, JP (2007) Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols. Biochem Biophys Res Commun 362, 340–346.
133.Williams, CM, El Mohsen, MA, Vauzour, D et al. (2008) Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 45, 295–305.
134.Macready, AL, Kennedy, OB, Ellia, JA et al. (2009) Flavonoids and cognitive function: A review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr 4, 227–242.
135.Joseph, JA, Shukitt-Hale, B, Denisova, NA et al. (1998) Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 18, 8047–8055.
136.Joseph, JA, Shukitt-Hale, B, Denisova, NA et al. (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19, 8114–8121.
137.Joseph, JA, Denisova, NA, Arendash, G et al. (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153–162.
138.Joseph, JA, Shukitt-Hale, B & Casadesus, G (2005) Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 81, Suppl., 313S–316S.
139.Joseph, JA, Shukitt-Hale, B & Lau, FC (2007) Fruit polyphenols and their effects on neuronal signaling and behavior in senescence. Ann N Y Acad Sci 1100, 470–485.
140.Shukitt-Hale, B, Lau, FC & Joseph, JA (2008) Berry fruit supplementation and the aging brain. J Agric Food Chem 56, 636–641.
141.Shukitt-Hale, B, Carey, A, Simon, L et al. (2006) Effects of Concord grape juice on cognitive and motor deficits in aging. Nutrition 22, 295–302.
142.Spencer, JPE (2009) Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr 4, 243–250.
143.Stangl, D & Thuret, S (2009) Impact of diet on adult hippocampal neurogenesis. Genes Nutr 4, 271–282.
144.Harris, KM & Kater, SB (1994) Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu Rev Neurosci 17, 341–371.
145.Maher, P, Akaishi, T & Abe, K (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci USA 103, 16568–16573.
146.Maher, P (2009) Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes Nutr 4, 297–307.
147.Pollard, SE, Whiteman, M & Spencer, JPE (2006) Modulation of peroxynitrite-induced fibroblast injury by hesperetin: a role for intracellular scavenging and modulation of ERK signalling. Biochem Biophys Res Commun 347, 916–923.
148.Pham, TA, Impey, S, Storm, DR et al. (1999) CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron 22, 63–72.
149.Impey, S, Smith, DM, Obrietan, K et al. (1998) Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci 1, 595–601.
150.Impey, S, Mark, M, Villacres, EC et al. (1996) Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron 16, 973–982.
151.Bourtchuladze, R, Frenguelli, B, Blendy, J et al. (1994) Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79, 59–68.
152.Tully, T, Bourtchouladze, R, Scott, R et al. (2003) Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2, 267–277.
153.Conkright, MD, Guzman, E, Flechner, L et al. (2003) Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol Cell 11, 1101–1108.
154.Finkbeiner, S (2000) CREB couples neurotrophin signals to survival messages. Neuron 25, 11–14.
155.Finkbeiner, S, Tavazoie, SF, Maloratsky, A et al. (1997) CREB: a major mediator of neuronal neurotrophin responses. Neuron 19, 1031–1047.
156.Bramham, CR & Messaoudi, E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76, 99–125.
157.Peng, S, Wuu, J, Mufson, EJ et al. (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93, 1412–1421.
158.Michalski, B & Fahnestock, M (2003) Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res 111, 148–154.
159.Egan, MF, Kojima, M, Callicott, JH et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269.
160.Schratt, GM, Nigh, EA, Chen, WG et al. (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J Neurosci 24, 7366–7377.
161.Yin, Y, Edelman, GM & Vanderklish, PW (2002) The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes. Proc Natl Acad Sci USA 99, 2368–2373.
162.Waltereit, R, Dammermann, B, Wulff, P et al. (2001) Arg3.1/Arc mRNA induction by Ca2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation. J Neurosci 21, 5484–5493.
163.Lyford, GL, Yamagata, K, Kaufmann, WE et al. (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433–445.
164.van Praag, H, Lucero, MJ, Yeo, GW et al. (2007) Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 27, 5869–5878.
165.Nagase, H, Yamakuni, T, Matsuzaki, K et al. (2005) Mechanism of neurotrophic action of nobiletin in PC12. D cells. Biochemistry 44, 13683–13691.
166.Matsuzaki, K, Miyazaki, K, Sakai, S et al. (2008) Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus. Eur J Pharmacol 578, 194–200.
167.Al Rahim, M., Nakajima, A, Saigusa, D et al. (2009) 4′-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade. Biochemistry 48, 7713–7721.
168.Fisher, ND, Hughes, M, Gerhard-Herman, M et al. (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21, 2281–2286.
169.Hirata, K, Shimada, K, Watanabe, H et al. (2004) Black tea increases coronary flow velocity reserve in healthy male subjects. Am J Cardiol 93, 1384–1388.
170.Janszky, I, Ericson, M, Blom, M et al. (2005) Wine drinking is associated with increased heart rate variability in women with coronary heart disease. Heart 91, 314–318.
171.Stein, JH, Keevil, JG, Wiebe, DA et al. (1999) Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100, 1050–1055.
172.Heiss, C, Dejam, A, Kleinbongard, P et al. (2003) Vascular effects of cocoa rich in flavan-3-ols. JAMA 290, 1030–1031.
173.Taubert, D, Berkels, R, Roesen, R et al. (2003) Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 290, 1029–1030.
174.Grassi, D, Lippi, C, Necozione, S et al. (2005) Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 81, 611–614.
175.Holt, RR, Schramm, DD, Keen, CL et al. (2002) Chocolate consumption and platelet function. JAMA 287, 2212–2213.
176.Sies, H, Schewe, T, Heiss, C et al. (2005) Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 81, Suppl., 304S–312S.
177.Keen, CL, Holt, RR, Oteiza, PI et al. (2005) Cocoa antioxidants and cardiovascular health. Am J Clin Nutr 81, Suppl., 298S–303S.
178.Schroeter, H, Heiss, C, Balzer, J et al. (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103, 1024–1029.
179.Fisher, ND & Hollenberg, NK (2006) Aging and vascular responses to flavanol-rich cocoa. J Hypertens 24, 1575–1580.
180.Heiss, C, Kleinbongard, P, Dejam, A et al. (2005) Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46, 1276–1283.
181.Wang-Polagruto, JF, Villablanca, AC, Polagruto, JA et al. (2006) Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J Cardiovasc Pharmacol 47, Suppl. 2, S177–S186.
182.Stein, JH, Keevil, JG, Wiebe, DA et al. (1999) Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100, 1050–1055.
183.Duffy, SJ, Keaney, JF Jr, Holbrook, M et al. (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104, 151–156.
184.Taubert, D, Roesen, R & Schomig, E (2007) Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 167, 626–634.
185.Grassi, D, Necozione, S, Lippi, C et al. (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398–405.
186.Karim, M, McCormick, K & Kappagoda, CT (2000) Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 130, Suppl., 2105S–2108S.
187.Leikert, JF, Rathel, TR, Muller, C et al. (2001) Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein. FEBS Lett 506, 131–134.
188.Leikert, JF, Rathel, TR, Wohlfart, P et al. (2002) Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106, 1614–1617.
189.Fitzpatrick, DF, Hirschfield, SL & Coffey, RG (1993) Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265, H774–H778.
190.Cishek, MB, Galloway, MT, Karim, M et al. (1997) Effect of red wine on endothelium-dependent relaxation in rabbits. Clin Sci (Lond) 93, 507–511.
191.Steffen, Y, Jung, T, Klotz, LO et al. (2007) Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: protection by (-)-epicatechin. Free Radic Biol Med 42, 955–970.
192.Ajay, M, Achike, FI, Mustafa, AM et al. (2006) Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aortae: comparative study with ascorbic acid. Clin Exp Pharmacol Physiol 33, 345–350.
193.Ajay, M, Achike, FI & Mustafa, MR (2007) Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid. Pharmacol Res 55, 385–391.
194.Commenges, D, Scotet, V, Renaud, S et al. (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16, 357–363.
195.Dai, Q, Borenstein, AR, Wu, Y et al. (2006) Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med 119, 751–759.
196.Fisher, ND, Sorond, FA & Hollenberg, NK (2006) Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 47, Suppl. 2, S210–S214.
197.Francis, ST, Head, K, Morris, PG et al. (2006) The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 47, Suppl. 2, S215–S220.
198.Gage, FH (2000) Mammalian neural stem cells. Science 287, 1433–1438.
199.Palmer, TD, Willhoite, AR & Gage, FH (2000) Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425, 479–494.
200.Nagahama, Y, Nabatame, H, Okina, T et al. (2003) Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur Neurol 50, 1–9.
201.Ruitenberg, A, den Heijer, T, Bakker, SL et al. (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57, 789–794.
202.Wang, Z, Fernandez-Seara, M, Alsop, DC et al. (2008) Assessment of functional development in normal infant brain using arterial spin labeled perfusion MRI. Neuroimage 39, 973–978.
203.Tapia-Arancibia, L, Rage, F, Givalois, L et al. (2004) Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 25, 77–107.
204.Givalois, L, Arancibia, S, Alonso, G et al. (2004) Expression of brain-derived neurotrophic factor and its receptors in the median eminence cells with sensitivity to stress. Endocrinology 145, 4737–4747.
205.Laske, C, Stransky, E, Eschweiler, GW et al. (2007) Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res 41, 600–605.
206.Laske, C, Stransky, E, Leyhe, T et al. (2007) BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res 41, 387–394.
207.Laske, C, Stransky, E, Leyhe, T et al. (2006) Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 113, 1217–1224.
208.Shimizu, E, Hashimoto, K, Okamura, N et al. (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54, 70–75.